CAPROCK Group Inc. lifted its position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST – Get Rating) by 66.7% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 100,000 shares of the company’s stock after acquiring an additional 40,000 shares during the quarter. CAPROCK Group Inc.’s holdings in LifeStance Health Group were worth $1,011,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of the company. Koshinski Asset Management Inc. bought a new position in LifeStance Health Group in the 4th quarter worth about $34,000. Harel Insurance Investments & Financial Services Ltd. bought a new position in LifeStance Health Group in the 4th quarter worth about $85,000. Metropolitan Life Insurance Co NY bought a new position in LifeStance Health Group in the 3rd quarter worth about $193,000. Voya Investment Management LLC bought a new position in LifeStance Health Group in the 3rd quarter worth about $248,000. Finally, California State Teachers Retirement System bought a new position in LifeStance Health Group in the 3rd quarter worth about $364,000. Institutional investors own 80.71% of the company’s stock.
LFST has been the subject of several analyst reports. The Goldman Sachs Group cut their target price on LifeStance Health Group from $15.00 to $10.00 and set a “neutral” rating for the company in a research note on Monday, March 21st. UBS Group downgraded LifeStance Health Group from a “buy” rating to a “neutral” rating and cut their target price for the stock from $19.00 to $10.00 in a research note on Thursday, March 17th. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $16.00.
LifeStance Health Group (NASDAQ:LFST – Get Rating) last announced its quarterly earnings results on Monday, May 9th. The company reported ($0.18) EPS for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.03). The company had revenue of $203.10 million during the quarter, compared to analysts’ expectations of $191.47 million. LifeStance Health Group had a negative return on equity of 22.41% and a negative net margin of 49.60%. The firm’s quarterly revenue was up 41.9% on a year-over-year basis. Equities research analysts expect that LifeStance Health Group, Inc. will post -0.48 earnings per share for the current year.
In related news, insider Warren Gouk sold 10,000 shares of LifeStance Health Group stock in a transaction that occurred on Thursday, June 9th. The stock was sold at an average price of $7.32, for a total transaction of $73,200.00. Following the sale, the insider now directly owns 6,265,330 shares in the company, valued at $45,862,215.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Michael K. Lester sold 328,615 shares of LifeStance Health Group stock in a transaction that occurred on Monday, June 13th. The shares were sold at an average price of $5.33, for a total value of $1,751,517.95. Following the sale, the chief executive officer now owns 23,148,931 shares in the company, valued at $123,383,802.23. The disclosure for this sale can be found here. Over the last quarter, insiders sold 477,159 shares of company stock worth $2,805,478.
LifeStance Health Group Company Profile (Get Rating)
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
- Get a free copy of the StockNews.com research report on LifeStance Health Group (LFST)
- Victoria’s Secret Stock is Out of the Box
- Downturn Gives These 3 Buys Juicy Dividend Yields
- Time For a Ride in Six Flags Stock
- Why Dollar General (NYSE: DG) Should Be In Your Portfolio
- Korn Ferry Is A Good Buy For The Recession And Beyond
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.